Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial

Yuan Dai; Lingli Zhang; Juehua Yu; Xin Zhou; Hua He; Yiting Ji; Kai Wang; Xiujuan Du; Xin Liu; Yun Tang; Shining Deng; Christelle Langley; Wei-Guang Li; Jun Zhang; Jianfeng Feng; Barbara J Sahakian; Qiang Luo; Fei Li

doi:10.1101/2020.09.18.20197640

Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial

Yuan Dai, Lingli Zhang, Juehua Yu, Xin Zhou, Hua He, Yiting Ji, Kai Wang, Xiujuan Du, Xin Liu, Yun Tang, Shining Deng, Christelle Langley, Wei-Guang Li, Jun Zhang, Jianfeng Feng, Barbara J Sahakian, View ORCID ProfileQiang Luo, Fei Li

doi: https://doi.org/10.1101/2020.09.18.20197640

Yuan Dai

1Department of Developmental and Behavioural Pediatric & Child Primary Care, Brain and Behavioural Research Unit of Shanghai Institute for Pediatric Research and MOE-Shanghai Key Laboratory for Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lingli Zhang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Juehua Yu

2Centre for Experimental Studies and Research, The First Affiliated Hospital of Kunming Medical University, Kunming, China

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xin Zhou

3Clinical Research Unit, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hua He

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yiting Ji

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kai Wang

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xiujuan Du

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Xin Liu

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yun Tang

4The School of Psychology and Cognitive Science, East China Normal University, Shanghai, China

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Shining Deng

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christelle Langley

5Department of Psychiatry and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wei-Guang Li

6Collaborative Innovation Center for Brain Science, Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jun Zhang

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jianfeng Feng

7MOE-Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Barbara J Sahakian

5Department of Psychiatry and the Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

7MOE-Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China

PhD, DSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Qiang Luo

7MOE-Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China

8State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science and Human Phenom Institute, Fudan University, Shanghai, China

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Qiang Luo
For correspondence: feili{at}shsmu.edu.cn qluo{at}fudan.edu.cn

Fei Li

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: feili{at}shsmu.edu.cn qluo{at}fudan.edu.cn

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplemental Methods[supplements/197640_file05.pdf]
Supplemental Table 1-8[supplements/197640_file06.pdf]

Appendix-SupplementaryMethods
Appendix-SupplementaryTables

View the discussion thread.

PreviousNext

Posted December 19, 2020.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial

medRxiv 2020.09.18.20197640; doi: https://doi.org/10.1101/2020.09.18.20197640

Share This Article:

Citation Tools

Improved symptoms following bumetanide treatment in children aged 3 to 6 years with autism spectrum disorder: a randomized, double-blind, placebo-controlled trial

medRxiv 2020.09.18.20197640; doi: https://doi.org/10.1101/2020.09.18.20197640

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Tweet Widget
Facebook Like
Google Plus One

Subject Area

Pediatrics

Subject Areas

All Articles

Addiction Medicine (349)
Allergy and Immunology (668)
Allergy and Immunology (668)
Anesthesia (181)
Cardiovascular Medicine (2648)
Dentistry and Oral Medicine (316)
Dermatology (223)
Emergency Medicine (399)
Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
Epidemiology (12228)
Forensic Medicine (10)
Gastroenterology (759)
Genetic and Genomic Medicine (4103)
Geriatric Medicine (387)
Health Economics (680)
Health Informatics (2657)
Health Policy (1005)
Health Systems and Quality Improvement (985)
Hematology (363)
HIV/AIDS (851)
Infectious Diseases (except HIV/AIDS) (13695)
Intensive Care and Critical Care Medicine (797)
Medical Education (399)
Medical Ethics (109)
Nephrology (436)
Neurology (3882)
Nursing (209)
Nutrition (577)
Obstetrics and Gynecology (739)
Occupational and Environmental Health (695)
Oncology (2030)
Ophthalmology (585)
Orthopedics (240)
Otolaryngology (306)
Pain Medicine (250)
Palliative Medicine (75)
Pathology (473)
Pediatrics (1115)
Pharmacology and Therapeutics (466)
Primary Care Research (452)
Psychiatry and Clinical Psychology (3432)
Public and Global Health (6527)
Radiology and Imaging (1403)
Rehabilitation Medicine and Physical Therapy (814)
Respiratory Medicine (871)
Rheumatology (409)
Sexual and Reproductive Health (410)
Sports Medicine (342)
Surgery (448)
Toxicology (53)
Transplantation (185)
Urology (165)